Home/Filings/4/0001213900-19-000051
4//SEC Filing

Bell John K 4

Accession 0001213900-19-000051

CIK 0001498382other

Filed

Jan 1, 7:00 PM ET

Accepted

Jan 2, 6:17 PM ET

Size

4.9 KB

Accession

0001213900-19-000051

Insider Transaction Report

Form 4
Period: 2018-12-31
Bell John K
Director
Transactions
  • Other

    Common Stock

    2018-12-31$0.34/sh+282$9696,429 total(indirect: Held by Onbelay Capital Inc.)
Footnotes (1)
  • [F1]The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock.

Issuer

DelMar Pharmaceuticals, Inc.

CIK 0001498382

Entity typeother

Related Parties

1
  • filerCIK 0001569585

Filing Metadata

Form type
4
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 6:17 PM ET
Size
4.9 KB